Revenue -7.8% drove PBT to a $4.2m loss as net debt/EBITDA hit 14x

NPAT moved from $4.2m to a $3.2m loss (-176.7%). EBITDA of $6.1m was almost exactly matched by negative operating cash flow of $6.1m, so cash conversion (OCF/EBITDA) was -99.9%.

Working capital absorbed cash heavily. Trade debtors rose 13.7% to $40.1m, lifting receivable days to 70.7 from 57.3. Inventory stood at $143.4m, equivalent to roughly 252 days of cost of sales. Total liabilities grew 23.6% to $155.7m while equity rose only 1.2%, leaving gross borrowings at $98.7m and net debt of $85.8m, equivalent to about 14x interim EBITDA.

The interim dividend was cut 60% to 1.0 cps (HY23: 2.5 cps). Gross margin was held at 60%, in line with the company's FY25 ambition.

A 7.8% revenue decline produced roughly a $10m swing in PBT. With pricing and 60% gross margin maintained, the loss is being driven by volume falling against a fixed cost base; the earnings model is highly sensitive to top-line softness in mainland China and key distribution accounts. This matters because any further consumer weakness in H2 FY24 has limited buffer before deeper losses.

The balance sheet is now the constraint, not the P&L. Inventory of $143.4m and receivable days at 70.7 (up 13.4 days) consumed cash even as EBITDA stayed positive, leaving FCF pre-lease at -$11.7m. Net debt/EBITDA at 14x on an interim basis is a leverage level that sharply narrows strategic optionality, and the 60% dividend cut signals the board is prioritising cash preservation.

Segment economics are uneven. Greater China contributed $45.0m of revenue (43.6% mix) at an 18.8% segment margin, while Australia/New Zealand delivered the strongest profitability at 32.3%. EMEA was loss-making and North America's 17.6% margin lags ANZ materially, so any further China softness has an outsized group-level effect.

Management commentary references a recent guidance reset on 1 February 2024 reflecting weaker mainland China consumer sentiment and the loss of some distribution agreements, with new North American agreements expected to contribute in H2 FY24, and reaffirms an FY25 outlook without a numeric anchor here.

Without a stated target or seasonality split, the release does not support a confident H2 bridge. What it does support is that the H2 starting point — elevated inventory, stretched receivables, and 14x leverage — leaves little room for further demand disappointment, and that any FY24 recovery depends on North American distribution wins landing on schedule.

EBITDA of $6.1m masks the fact that depreciation, amortisation and finance costs took the group to a PBT loss, and the headline NPAT loss of $3.2m is flattered relative to PBT only because tax provided a credit at an effective rate of 23.5% (HY23: 28.1%) — PBT growth of -172.1% is the cleaner operating read.

Payout ratio versus pre-lease FCF is suppressed because the source-backed cash-dividend bridge is unavailable.

This briefing cannot assess covenant headroom, the scheduled phasing of the North American distribution wins, or whether inventory carries impairment risk at current sell-through rates.